Treat · AM · PM

NeuGlow 2% Encapsulated Salicylic Acid + 1% AC.Net™ Acne Serum (30ml) | Fast-Acting Clinical Formula to Reduce Acne, Blackheads & Whiteheads.

With 1% Patented AC.Net Source From Sederma United Kingdom

NeuGlow 2% Encapsulated Salicylic Acid + 1% Patented AC.Net™ Acne Serum is a precision-engineered blemish-clarifying treatment formulated to target acne at its cellular source. Featuring advanced micro-encapsulation technology, it delivers time-released 2% BHA deep into follicular pores to dissolve sebum, clear blackheads, and prevent whiteheads without provoking transepidermal water loss.

Best for

  • Active acne
  • Excess oil
  • Clogged pores
  • Back Acne
  • Chest Acne
  • Keratosis Pilaris (Chicken Skin)
  • Blackhead/Whitehead
Choose a pack

₹349₹475incl. of all taxes

  • Free delivery on orders above ₹349
  • Secure payment via Razorpay
  • Expiry: March 2028

In use

See it in use

Influencers using this product.

Your 8-Week Skin Improvement Journey

97% users saw Acne Reduction & Radiant Skin in 8 Week

  1. Week 2

    Sebum Regulation

  2. Week 4

    Pore Decongestion

  3. Week 6

    Acne Lesion Reduction

  4. Week 8

    Complexion Uniformity

97% users saw Acne Reduction & Radiant Skin  in 8 Week

What’s inside

  • 2% Encapsulated Salicylic Acid
  • 1% AC.NET (patented)
  • Witch Hazel Extract
  • Willow Bark Extract

How to use

  1. 1Cleanse and pat the skin dry.
  2. 2Apply two to three drops to the face at night, avoiding the eye area. Press in, don’t rub.
  3. 3If your skin is reactive, start every other night for the first week.
  4. 4Use a sunscreen in the morning.

Ideal for

Suitable for oily, Acne-prone skin with active Acne, Excess oil, and clogged pores. Also suitable for use on the chest and back Acne.

Pairs with

The science behind the actives

Figures below come from the ingredient supplier’s own studies, at the concentration they tested. They describe the ingredient, not this finished product.

AC.NET™

Oleanolic acid and NDGA in an osmotic gel. Acts on excess sebum, hyperkeratosis, inflammation and acne bacteria.

Sederma (Croda International Plc), France · Patent WO 03/028692 · 1% in this product

  • −44% sebum (seborrhoea)in vivo, Sebutape®, 9 volunteers, 6 weeks, at 3%
  • −31% active sebaceous glandsin vivo, Sebutape®, 9 volunteers, 6 weeks, at 3%
  • −35% comedonesin vivo, lesion count, 20 volunteers, 8 weeks, at 3%